Australia's most trusted
source of pharma news
Saturday, 02 August 2025
Posted 1 August 2025 PM
Company restructures keep on coming with news this week that MSD is the latest to experience workforce downsizing, our top story this week.
The so-called 'multiyear optimisation initiative' will see jobs go in administrative, sales and R&D positions though the number is not known. As well, the company intends to downsize its real estate footprint with a plan to save US$3 billion by 2027. Find out what's behind the shake-up in: Jobs go in major cost-cutting
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.